Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A double-blind, placebo-controlled treatment trial evaluating Lactobacillus gasseri OLL2716 (yogurt preparation) vs placebo in 64 patients with Acetylsalicylic Acid (ASA) / Aspirin-induced small bowel injuries (ulcers, erosions, reddened lesions, bleeding)
Outcome measures:
Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease (FSSG) and Gastrointestinal Symptom Rating Scale (GSRS) scores
Conclusion:
The Lactobacillus gasseri OLL2716 group, compared to the placebo group, exhibited a notable reduction in small bowel mucosal breaks and reddened lesions after a period of 6 weeks (p < 0.01). Add…